Journal of Cystic Fibrosis
Volume 2, Issue 1 , Pages 25-28, March 2003

A pilot study of zafirlukast as an anti-inflammatory agent in the treatment of adults with cystic fibrosis

  • S.P. Conway

      Affiliations

    • Regional Adult CF Unit, Seacroft Hospital, York Road, Leeds, UK
    • Corresponding Author InformationCorresponding author
    • ,
  • C. Etherington

      Affiliations

    • Regional Adult CF Unit, Seacroft Hospital, York Road, Leeds, UK
    • ,
  • D.G. Peckham

      Affiliations

    • Regional Adult CF Unit, Seacroft Hospital, York Road, Leeds, UK
    • ,
  • A. Whitehead

      Affiliations

    • Pharmacy Department, Seacroft Hospital, York Road, Leeds, UK

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1569-1993(02)00142-X

doi:10.1016/S1569-1993(02)00142-X

Journal of Cystic Fibrosis
Volume 2, Issue 1 , Pages 25-28, March 2003

Article Tools

* Image Usage & Resolution